A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia

A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia

Abstract Passive immunotherapy with convalescent plasma may be the only available agent during the early phases of a pandemic. Here, we report safety and efficacy of high-titer convalescent plasma for COVID-19 pneumonia. Double-blinded randomized multicenter placebo-controlled trial of adult patient...

Full description

Bibliographic Details
Main Authors: Louise Thorlacius-Ussing, Patrick Terrence Brooks, Henrik Nielsen, Bitten Aagaard Jensen, Lothar Wiese, Susanne Gjørup Sækmose, Stine Johnsen, Mikkel Gybel-Brask, Isik S. Johansen, Mie Topholm Bruun, Nina Breinholdt Stærke, Lars Østergaard, Christian Erikstrup, Sisse Rye Ostrowski, Keld Mikkelsen Homburg, Jørgen Georgsen, Susan Mikkelsen, Håkon Sandholdt, Cæcilie Leding, Nichlas Hovmand, Clara Lundetoft Clausen, Michaela Tinggaard, Karen Brorup Heje Pedersen, Katrine Kjær Iversen, Sandra Tingsgård, Simone Bastrup Israelsen, Thomas Benfield
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-19629-z

Internet

https://doi.org/10.1038/s41598-022-19629-z

Similar Items